Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Inozyme Pharma Inc

INZY
Current price
3.85 USD -0.03 USD (-0.77%)
Last closed 3.85 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 242 719 552 USD
Yield for 12 month +173.05 %
Week
Month
Year
INZY
21.11.2021 - 28.11.2021

Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein, which is in Phase 1/2 clinical trials for the treatment of ENPP1 and ABCC6 deficiency, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 321 Summer Street, Boston, MA, United States, 02210

Analytics

WallStreet Target Price

22 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -71 548 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.15 %
PEG Ratio
Return On Equity TTM -46.22 %
Wall Street Target Price 22 USD
Revenue TTM
Book Value 2.59 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.44 USD
Diluted Eps TTM -1.44 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics INZY

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.2394
Price Book MRQ 0.3806

Financials INZY

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators INZY

For 52 weeks

0.99 USD 7.33 USD
50 Day MA 3.53 USD
Shares Short Prior Month 2 456 983
200 Day MA 4.63 USD
Short Ratio 5.21
Shares Short 2 078 340
Short Percent 3.39 %